PRMT3 and colorectal carcinoma: Moreover, SGC707 and 5‐FU exhibit a significant synergistic effect on chemoradiation both in PDOs and CRC cell lines (Figure 2G; Figure S2L, Supporting Information), further suggesting that effects of PRMT3 on chemoradiotherapy were dependent on its enzyme activity.